Seasonale warned by FDA for ads

Share this article:

A television commercial for Barr Pharmaceuticals's Seasonale misleads consumers by excluding risk information to make the birth control pill seem safer, U.S. health regulators warned in a letter.
The commercial suggests use of the oral contraceptive leads to only four menstrual periods a year but fails to mention frequent and sometimes substantial bleeding, the FDA said in the Dec. 29 letter.

Barr's advertisement, which was created by PACE Advertising of Parsippany, N.J., plays down the risk of irregular menstrual bleeding that can be as heavy as a regular period by suggesting it would subside with continued use of the pill, the letter said.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Miss Idaho shows off diabetes pump

NPR reports that the move has made Sierra Sandison a type 1 diabetes hero and that users have given the Facebook photo over 4,000 "likes."

Roche is hungry, not starving for M&A

CEO Severin Schwan tells Reuters that the Swiss firm will be looking for small acquisitions and partnerships.

AbbVie nabs Shire for $54B

AbbVie, in the latest example of a US drugmaker seeking to lower its tax rate, said today that it's buying Dublin-based Shire for $54 billion.